AAAAAA
Results:
1-25
|
Results: 25
Authors:
Wilcock, GK
Citation: Gk. Wilcock, Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial (vol 321, pg 1445, 2000), BR MED J, 322(7278), 2001, pp. 90-90
Authors:
Greene, JRT
Radenahmad, N
Wilcock, GK
Neal, JW
Pearson, RCA
Citation: Jrt. Greene et al., Accumulation of calbindin in cortical pyramidal cells with ageing; a putative protective mechanism which fails in Alzheimer's disease, NEUROP AP N, 27(5), 2001, pp. 339-342
Authors:
Allen, SJ
Robertson, AGS
Tyler, SJ
Wilcock, GK
Dawbarn, D
Citation: Sj. Allen et al., Recombinant human nerve growth factor for clinical trials: protein expression, purification, stability and characterisation of binding to infusion pumps, J BIOCH BIO, 47(3), 2001, pp. 239-255
Authors:
Baddeley, AD
Baddeley, HA
Bucks, RS
Wilcock, GK
Citation: Ad. Baddeley et al., Attentional control in Alzheimer's disease, BRAIN, 124, 2001, pp. 1492-1508
Authors:
Robertson, AGS
Banfield, MJ
Allen, SJ
Dando, JA
Mason, GGF
Tyler, SJ
Bennett, GS
Brain, SD
Clarke, AR
Naylor, RL
Wilcock, GK
Brady, RL
Dawbarn, D
Citation: Ags. Robertson et al., Identification and structure of the nerve growth factor binding site on TrkA, BIOC BIOP R, 282(1), 2001, pp. 131-141
Authors:
Wilcock, GK
Lilienfeld, S
Gaens, E
Citation: Gk. Wilcock et al., Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial, BR MED J, 321(7274), 2000, pp. 1445-1449
Authors:
Love, S
Barber, R
Srinivasan, A
Wilcock, GK
Citation: S. Love et al., Activation of caspase-3 in permanent and transient brain ischaemia in man, NEUROREPORT, 11(11), 2000, pp. 2495-2499
Authors:
Byrne, LMT
Wilson, PMA
Bucks, RS
Hughes, AO
Wilcock, GK
Citation: Lmt. Byrne et al., The sensitivity to change over time of the Bristol Activities of Daily Living Scale in Alzheimer's disease, INT J GER P, 15(7), 2000, pp. 656-661
Authors:
Wilcock, GK
Citation: Gk. Wilcock, Treatment for Alzheimer's disease, INT J GER P, 15(6), 2000, pp. 562-565
Authors:
Eastley, R
Wilcock, GK
Bucks, RS
Citation: R. Eastley et al., Vitamin B12 deficiency in dementia and cognitive impairment: The effects of treatment on neuropsychological function, INT J GER P, 15(3), 2000, pp. 226-233
Authors:
Love, S
Barber, R
Wilcock, GK
Citation: S. Love et al., Neuronal death in brain infarcts in man, NEUROP AP N, 26(1), 2000, pp. 55-66
Authors:
Bucks, RS
Singh, S
Cuerden, JM
Wilcock, GK
Citation: Rs. Bucks et al., Analysis of spontaneous, conversational speech in dementia of Alzheimer type: Evaluation of an objective technique for analysing lexical performance, APHASIOLOGY, 14(1), 2000, pp. 71-91
Authors:
Bauer, ME
Vedhara, K
Perks, P
Wilcock, GK
Lightman, SL
Shanks, N
Citation: Me. Bauer et al., Chronic stress in caregivers of dementia patients is associated with reduced lymphocyte sensitivity to glucocorticoids, J NEUROIMM, 103(1), 2000, pp. 84-92
Authors:
Byrne, L
Bucks, RS
Wilcock, GK
Citation: L. Byrne et al., Mini mental state examination, LANCET, 355(9200), 2000, pp. 314-315
Authors:
Culpan, D
MacGowan, S
Laundy, GJ
Wilcock, GK
Citation: D. Culpan et al., HLA-DR3 and DQA10401: possible risk factors in Alzheimer's disease, ALZHEIM REP, 2(2), 1999, pp. 93-97
Authors:
Love, S
Barber, R
Wilcock, GK
Citation: S. Love et al., Neuronal accumulation of poly(ADP-ribose) after brain ischaemia, NEUROP AP N, 25(2), 1999, pp. 98-103
Authors:
Ahmed, ARH
MacGowan, SH
Culpan, D
Jones, RW
Wilcock, GK
Citation: Arh. Ahmed et al., The -491A/T polymorphism of the apolipoprotein E gene is associated with the ApoE epsilon 4 allele and Alzheimer's Disease, NEUROSCI L, 263(2-3), 1999, pp. 217-219
Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination
Authors:
Vedhara, K
Cox, NKM
Wilcock, GK
Perks, P
Hunt, M
Anderson, S
Lightman, SL
Shanks, NM
Citation: K. Vedhara et al., Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination, LANCET, 353(9153), 1999, pp. 627-631
Authors:
Francis, PT
Palmer, AM
Snape, M
Wilcock, GK
Citation: Pt. Francis et al., The cholinergic hypothesis of Alzheimer's disease: a review of progress - Reply, J NE NE PSY, 67(4), 1999, pp. 558-558
Authors:
Francis, PT
Palmer, AM
Snape, M
Wilcock, GK
Citation: Pt. Francis et al., The cholinergic hypothesis of Alzheimer's disease: a review of progress, J NE NE PSY, 66(2), 1999, pp. 137-147
Authors:
Love, S
Barber, R
Wilcock, GK
Citation: S. Love et al., Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease, BRAIN, 122, 1999, pp. 247-253
Authors:
Allen, SJ
Wilcock, GK
Dawbarn, D
Citation: Sj. Allen et al., Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease, BIOC BIOP R, 264(3), 1999, pp. 648-651
Authors:
Lin, WR
Graham, J
MacGowan, SM
Wilcock, GK
Itzhaki, RF
Citation: Wr. Lin et al., Alzheimer's disease, herpes virus in the brain, apolipoprotein E4 and herpes labialis. (vol 1, pg 173, 1998), ALZHEIM REP, 1(4), 1998, pp. 274-274
Authors:
Lin, WR
Graham, J
MacGowan, SM
Wilcock, GK
Itzhaki, RF
Citation: Wr. Lin et al., Alzheimer's disease, herpes virus in brain, apolipoprotein E4 and herpes labialis, ALZHEIM REP, 1(3), 1998, pp. 173-178
Authors:
Roberts, CJC
Ford, JM
Truman, CA
Scott, M
Makela, PM
Wilcock, GK
Citation: Cjc. Roberts et al., Assessment of the value of therapeutic monitoring of tacrine in Alzheimer's disease, EUR J CL PH, 54(9-10), 1998, pp. 721-724
Risultati:
1-25
|